The One Clause That Reshaped a Billion-Dollar Merger

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

The One Clause That Reshaped a Billion-Dollar Merger

Listen for free

View show details

In this episode of The Business Negotiation Podcast, Lucas and Luna dissect a deal-breaking moment from the 2023 merger of two medical-device giants. When a single Material Adverse Change clause nearly killed a $1.9 billion acquisition, the negotiators had to re-engineer the entire contract structure in 72 hours. Lucas walks through the specific language that created the impasse—a clause about pending FDA approvals—and how the buyer's team turned a binary risk into a sliding-scale earnout. Luna challenges whether the MAC clause was actually a red herring for deeper valuation disagreements. The episode zooms in on one sentence from the original purchase agreement and shows how rewriting it saved the deal. Listeners will walk away with a practical tool for their next high-stakes negotiation: the conditional escalation clause. #MaterialAdverseChange #MACClause #MergerAndAcquisition #MedicalDevices #BillionDollarDeal #FDAApproval #Earnout #NegotiationStrategy #ContractLanguage #DealBreak #MergerNegotiation #BusinessNegotiation #FexingoBusiness #BusinessPodcast #LucasAndLuna #DealStructure #RiskAllocation #ConditionalEscalation Keep every episode free: buymeacoffee.com/fexingo

No reviews yet